Teladoc Health (NYSE:TDOC) Stock Price Expected to Rise, Bank of America Analyst Says

Teladoc Health (NYSE:TDOC) had its price target lifted by analysts at Bank of America from $11.50 to $13.50 in a note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “neutral” rating on the health services provider’s stock. Bank of America‘s target price points to a potential downside of 0.04% from the stock’s previous close.

Several other analysts have also recently weighed in on TDOC. Royal Bank of Canada lifted their price objective on Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Deutsche Bank Aktiengesellschaft lifted their price target on Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research report on Friday, November 1st. Barclays increased their price objective on Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. Piper Sandler restated an “overweight” rating and set a $13.00 target price (up previously from $11.00) on shares of Teladoc Health in a report on Wednesday, December 4th. Finally, Oppenheimer decreased their price target on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research note on Friday, January 24th. Fourteen investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $12.08.

Teladoc Health Trading Up 7.6 %

NYSE:TDOC opened at $13.51 on Wednesday. Teladoc Health has a 12 month low of $6.76 and a 12 month high of $21.74. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The company has a 50-day moving average price of $10.22 and a 200-day moving average price of $9.25. The stock has a market cap of $2.33 billion, a price-to-earnings ratio of -2.34 and a beta of 1.05.

Insider Buying and Selling at Teladoc Health

In related news, insider Carlos Nueno sold 2,389 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the completion of the sale, the insider now directly owns 2,890 shares in the company, valued at approximately $34,477.70. The trade was a 45.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.95% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Teladoc Health

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Whipplewood Advisors LLC acquired a new position in Teladoc Health during the 4th quarter worth $29,000. Versant Capital Management Inc lifted its stake in Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 2,441 shares during the last quarter. Lindbrook Capital LLC lifted its position in shares of Teladoc Health by 78.9% during the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock valued at $33,000 after acquiring an additional 1,612 shares during the last quarter. Blue Trust Inc. boosted its position in shares of Teladoc Health by 84.5% in the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock valued at $40,000 after purchasing an additional 1,854 shares during the period. Finally, Sterling Capital Management LLC increased its position in shares of Teladoc Health by 776.7% in the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider’s stock worth $42,000 after acquiring an additional 4,101 shares in the last quarter. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.